Latest updates for Eliquis

Fresh curated links around Eliquis are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Bristol Myers Squibb-Pfizer Alliance to sell Eliquis on Mark Cuban’s Cost Plus Drugs
  • Novartis narrows focus for anticoagulant after failure to best Eliquis in phase 3 trial
  • Delayed Administration of Apixaban and Rivaroxaban Reduces the Risk of Postoperative Bleeding Without Increasing Thrombo

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

roi-nj.com /1 month ago

Bristol Myers Squibb-Pfizer Alliance to sell Eliquis on Mark Cuban’s Cost Plus Drugs

The Bristol Myers Squibb–Pfizer Alliance announced the launch of a collaboration with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs) to offer Eliquis (apixaban) on CostPlusDru...

Read source
fiercebiotech.com /1 month ago

Novartis narrows focus for anticoagulant after failure to best Eliquis in phase 3 trial

A little over a year after reabsorbing its anticoagulant abelacimab, Novartis has now terminated two phase 3 trials for the antibody.

Read source
arthroplastyjournal.org /1 month ago

Delayed Administration of Apixaban and Rivaroxaban Reduces the Risk of Postoperative Bleeding Without Increasing Thrombo...

The optimal timing for initiation of anticoagulation using direct oral anticoagulants (DOACs) following total hip arthroplasty (THA) remains a subject of debate. While DOACs are ef...

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Eliquis

arthroplastyjournal.org

Recent coverage from public sources
Public source

fiercebiotech.com

Recent coverage from public sources
Public source

roi-nj.com

Recent coverage from public sources
Public source